文献速递复苏、休克与脓毒症心脑血管急症

GO-FAR评分在中国人群院内院外心脏骤停患者神经功能预后预测中的临床价值验证

[Validation the clinical value of good outcome following attempted resuscitation scores in Chinese populations in predicting the prognosis of in-hospital cardiac arrest].
PubMed 文献 · Zhonghua Wei Zhong Bing Ji Jiu Yi Xue · 2022-01-01
一句话结论单中心回顾性研究显示,GO-FAR评分可预测中国IHCA患者出院时神经功能预后,评分越高预后越差。

该研究回顾性分析了自贡市第四人民医院2020年1月1日至12月31日收治的230例IHCA患者,以CPC评分1分为终点,按GO-FAR评分分为≤0、1-8、9-20和≥21四组。以≤0组为参照,1-8组OR为0.54(95%CI 0.17-1.53,P=0.250),9-20组OR为0.17(95%CI 0.02-0.67,P=0.009),≥21组OR为0.25(95%CI 0.05-0.85,P=0.025)。GO-FAR评分预测良好神经功能预后的AUC为0.653(95%CI 0.529-0.777,P=0.015),Hosmer-Lemeshow检验P=0.311,提示预测值与实际值无显著差异。作者认为GO-FAR评分可用于中国人群IHCA患者神经功能预后预测,帮助临床医生预测心肺复苏预后并向患者或家属提出关键治疗建议。

要点

  • 230例IHCA患者中仅23例(10.0%)获得良好神经功能预后(CPC评分1分)。
  • 以GO-FAR评分≤0组为参照,9-20组OR为0.17(95%CI 0.02-0.67,P=0.009),≥21组OR为0.25(95%CI 0.05-0.85,P=0.025),1-8组OR为0.54(95%CI 0.17-1.53,P=0.250)。
  • GO-FAR评分预测良好神经功能预后的AUC为0.653(95%CI 0.529-0.777,P=0.015)。
  • Hosmer-Lemeshow检验P=0.311,提示预测值与实际值无显著差异。
  • 年龄、入院时神经功能正常、急性卒中、转移性肿瘤、脓毒症等GO-FAR相关变量在组间差异均有统计学意义(均P<0.05)。

适用人群与场景

  • 2020年1月1日至12月31日入住自贡市第四人民医院的IHCA患者,共230例,其中男性130例,年龄74(65,81)岁。

诊断标准与关键阈值

  • 以格拉斯哥-匹兹堡脑功能分类(CPC)评分1分作为良好神经功能预后的终点。
  • 按GO-FAR评分分为4组:≤0组、1-8组、9-20组和≥21组。

研究设计与关键结果

  • 研究类型为单中心回顾性分析,纳入230例IHCA患者,23例(10.0%)获得良好神经功能预后。
  • GO-FAR相关变量包括年龄、入院时神经功能正常、急性卒中、转移性肿瘤、脓毒症、内科非心脏入院、肝功能不全、低血压、肾功能不全或透析、呼吸功能不全、肺炎等在组间差异均有统计学意义(均P<0.05)。
  • 以GO-FAR评分≤0组为参照,1-8组良好神经功能预后的OR为0.54(95%CI 0.17-1.53,P=0.250),9-20组OR为0.17(95%CI 0.02-0.67,P=0.009),≥21组OR为0.25(95%CI 0.05-0.85,P=0.025)。
  • GO-FAR评分预测良好神经功能预后的AUC为0.653(95%CI 0.529-0.777,P=0.015)。
  • Hosmer-Lemeshow检验P=0.311,提示预测值与实际值无显著差异。

证据类型、等级与局限

  • 证据类型:单中心回顾性分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为GO-FAR评分可应用于中国人群IHCA患者神经功能预后预测,帮助临床医生预测心肺复苏预后,并向患者或家属提出关键治疗建议。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「红旗征与不能漏的情况」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

OBJECTIVE: To verify the clinical value of the good outcome following attempted resuscitation (GO-FAR) score in predicting the neurological status of patients with in-hospital cardiac arrest (IHCA) in the Chinese population.

METHODS: The clinical data of patients with IHCA who were admitted to the Zigong Fourth People's Hospital from January 1 to December 31, 2020 were retrospectively analyzed. Used Glasgow-Pittsburgh cerebral performance category (CPC) score 1 point as the end point, the subjects were divided into 4 groups according to the score: ≤ 0 group, 1-8 group, 9-20 group and ≥ 21 group. Taken the group which GO-FAR score ≤ 0 as the reference group, the odds ratio (OR) of the other three groups compared with this group was calculated. The receiver operator characteristic curve (ROC curve) was performed to evaluate the predictive value of the GO-FAR score in favorable neurological outcome. A calibration curve was drawn for the Hosmer-Lemeshow test to analyze the degree of calibration of the GO-FAR score for predicting good neurological outcome.

RESULTS: A total of 230 IHCA patients were enrolled in the study, including 130 males, aged 74 (65, 81) years old, and 23 case (10.0%) had good neurological prognosis. There were statistically significant differences in GO-FAR-related variables, including age, a normal neurological function on admitted, acute stroke, metastatic cancer, septicemia, medical noncardiac admission, hepatic insufficiency, hypotension, renal insufficiency or dialysis, respiratory insufficiency, pneumonia, etc (all P < 0.05). Taken the GO-FAR score ≤ 0 group as the reference group, the OR values of good neurological prognosis in the GO-FAR score 1-8 group were 0.54 [95% confidence interval (95%CI) was 0.17-1.53, P = 0.250], 9-20 group were 0.17 (95%CI was 0.02-0.67, P = 0.009) and ≥ 21 group were 0.25 (95%CI was 0.05-0.85, P = 0.025). The area under the ROC curve (AUC) of the GO-FAR score for predicting favorable neurological outcome in IHCA patients was 0.653 (95%CI was 0.529-0.777, P = 0.015) and there was no significant difference in Hosmer-Lemeshow test (P = 0.311). All these suggested that there was no significant difference between the predicted value and the actual value.

CONCLUSIONS: GO-FAR score can be applied to predict neurological prognosis of IHCA patients in Chinese population. It can help clinicians to predict the prognosis of cardio-pulmonary resuscitation (CPR) and propose critical recommendations in treatment for these patients or their families.

来源:Zhonghua Wei Zhong Bing Ji Jiu Yi Xue,查看原文。版权归原作者所有。

参考来源

  1. Ren Y, Ye L, Huang X, et al. [Validation the clinical value of good outcome following attempted resuscitation scores in Chinese populations in predicting the prognosis of in-hospital cardiac arrest]. Zhonghua Wei Zhong Bing Ji Jiu Yi Xue. 2022. PMID: 36567575. doi:10.3760/cma.j.cn121430-20220317-00256

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。